The hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99
- Brand / company
- Rising Pharma Holding, Inc.
- Codes / lots
- Lot #: DTB23111A, Exp 8/31/2025
- Distribution
- Nationwide in the USA.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 26 Mar 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.